vTv Therapeutics Inc.
VTVT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $17 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $22 |
| Gross Profit | $0 | $0 | $0 | -$5 |
| % Margin | – | – | – | -29.4% |
| R&D Expenses | $7,020 | $4,103 | $2,830 | $2,234 |
| G&A Expenses | $3,679 | $3,618 | $3,673 | $2,675 |
| SG&A Expenses | $3,679 | $3,618 | $3,673 | $2,675 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$22 |
| Operating Expenses | $10,699 | $7,721 | $6,503 | $4,887 |
| Operating Income | -$10,699 | -$7,721 | -$6,503 | -$4,892 |
| % Margin | – | – | – | -28,776.5% |
| Other Income/Exp. Net | $354 | $341 | $286 | $455 |
| Pre-Tax Income | -$10,345 | -$7,380 | -$6,217 | -$4,437 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,698 | -$6,046 | -$5,092 | -$3,634 |
| % Margin | – | – | – | -21,376.5% |
| EPS | -1.08 | -0.92 | -0.77 | -0.63 |
| % Growth | -17.4% | -19.5% | -22.2% | – |
| EPS Diluted | -1.08 | -0.92 | -0.77 | -0.63 |
| Weighted Avg Shares Out | 8,056 | 6,587 | 6,583 | 5,771 |
| Weighted Avg Shares Out Dil | 8,056 | 6,587 | 6,583 | 5,771 |
| Supplemental Information | – | – | – | – |
| Interest Income | $399 | $275 | $331 | $429 |
| Interest Expense | $5 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $3 | $9 | $22 |
| EBITDA | -$10,338 | -$7,718 | -$6,494 | -$4,415 |
| % Margin | – | – | – | -25,970.6% |